Beta Bionics company information, Employees & Contact Information

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 GlobeNewswire

Analysts expect Beta Bionics patch pump launch by 2027 Drug Delivery Business

Beta Bionics, maker of ‘bionic pancreas,’ files for IPO medtechdive.com

Artificial pancreas maker Beta Bionics aims to raise $120M in Nasdaq IPO Fierce Biotech

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance GlobeNewswire

Beta Bionics Announces Closing of a $60 Million Series E Financing Newswire.com

Beta Bionics' road to bringing its bionic pancreas to market Drug Delivery Business

Beta Bionics Announces Board Appointment of Gerard Michel Yahoo Finance

Beta Bionics raises $204M in IPO medtechdive.com

FDA Clears Beta Bionics' iLet Bionic Pancreas – No Carb Counting Required Making Sense of Diabetes

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes The New England Journal of Medicine

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering GlobeNewswire

Beta Bionics to Present at the Bank of America Securities Health Care Conference Yahoo Finance

Beta Bionics raises $100M to challenge Medtronic, Tandem for automated insulin dosing market medtechdive.com

Beta Bionics Files Registration Statement for Proposed Initial Public Offering GlobeNewswire

Beta Bionics Announces Closing of $234.6 Million Initial GlobeNewswire

Beta Bionics Receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System GlobeNewswire

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 GlobeNewswire

Beta Bionics targets $114M IPO raise to fund insulin pump development medtechdive.com

Beta Bionics Partners with Abbott to Integrate iLet Bionic Pancreas with FreeStyle Libre 3 Plus Beyond Type 1

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence Newswire.com

Beta Bionics earns pharmacy benefit win for bionic pancreas Drug Delivery Business

Beta Bionics posts Q1 sales beat, raises 2025 guidance Drug Delivery Business

Here’s Why Beta Bionics Filing for an IPO Is a Big Deal Medical Device and Diagnostic industry

Beta Bionics CEO, CFO on how to take a company public medtechdive.com

Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor MassDevice

Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus Drug Delivery Business

Beta Bionics: Guiding Conservative After All (NASDAQ:BBNX) Seeking Alpha

Beta Bionics Aims For IPO To Cover Heavy Losses (BBNX) Seeking Alpha

Introducing Beta Bionics: Bringing the iLet Bionic Pancreas to Market Making Sense of Diabetes

More Choices Available for Abbott, Dexcom, Tandem, and iLet Making Sense of Diabetes

FDA clears Beta Bionics' insulin pump and automated dosing software to create artificial pancreas Fierce Biotech

Beta Bionics Announces Closing of $57 Million Series C Financing GlobeNewswire

With Beta Bionics collab, Dexcom lines up G7 sensor’s 2nd insulin pump partner in as many days Fierce Biotech

Diabetes Tech Leader Beta Bionics Announces Triple Conference Lineup: Wells Fargo, Morgan Stanley, Baird Events Stock Titan

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics Business Wire

Beta Bionics raises $204m to kickstart medtech IPO season Medical Device Network

Newly public Beta Bionics reports sales surge; Dexcom hires CCO medtechdive.com

What’s Coming from Beta Bionics and Bigfoot? Exciting Next-Gen Automated Insulin Delivery Making Sense of Diabetes

Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas Newswire.com

Beta Bionics BBNX Q2 2025 Earnings Call Transcript The Motley Fool

Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System Newswire.com

Life-changing ‘bionic pancreas’ for type 1 diabetes available in the US Diabetes UK

Novo Nordisk Partners with Beta Bionics and Invests $5 Million Making Sense of Diabetes

Hope for the Battle against Type 1 Diabetes Boston University

Beta Bionics IPO Blossoms, Venture Global Disappoints Access IPOs

Beta Bionics takes step toward $25M financing round Fierce Biotech